Latest headlines
AstraZeneca PLC News
The latest AstraZeneca PLC (AZN) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these AZN headlines next to the live AstraZeneca PLC Fear and Greed Index.
Latest AstraZeneca PLC Headlines54
BioMarin Inks $490M Deal to Buy Rare Bone Disease Treatment
zacks.com · Aug 19, 2026
AstraZeneca Vs. Bristol-Myers Squibb: Who's The Better Bargain For Investors?
seekingalpha.com · Aug 19, 2026
AZN Ends NSCLC Study for Bispecific Antibody Over Unlikely Success
zacks.com · Aug 18, 2026
AstraZeneca maintains Citi 'buy' rating despite mixed pipeline updates
proactiveinvestors.co.uk · Aug 18, 2026
AstraZeneca Reports Positive Lung Cancer Trials Amid Pipeline Setback
gurufocus.com · Aug 17, 2026
HUTCHMED shares rise as lung cancer drug trial hits key targets
proactiveinvestors.co.uk · Aug 17, 2026
AstraZeneca Reports Mixed Lung Cancer Trial Outcomes From Three Pivotal Studies
benzinga.com · Aug 17, 2026
TAGRISSO® (osimertinib) plus savolitinib demonstrated statistically significant and clinically meaningful improvements in progression-free and overall survival in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO
businesswire.com · Aug 17, 2026
AstraZeneca lung cancer drug combination extends survival in trial
proactiveinvestors.co.uk · Aug 17, 2026
AstraZeneca Ends Phase Three Lung Cancer Drug Trial After Review
wsj.com · Aug 17, 2026
AstraZeneca to discontinue late-stage lung cancer trial for volrustomig
reuters.com · Aug 17, 2026
Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?
fool.com · Aug 13, 2026
Do Options Traders Know Something About AstraZeneca Stock We Don't?
zacks.com · Aug 11, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
prnewswire.com · Aug 6, 2026
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale
cnbc.com · Aug 6, 2026
Deal or No Deal, AstraZeneca Stock Is a Bargain
wsj.com · Aug 6, 2026
'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
reuters.com · Aug 5, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
globenewswire.com · Aug 4, 2026
Brokers split on AstraZeneca merger talk as shares recover some ground
proactiveinvestors.com · Aug 4, 2026
Brokers split on AstraZeneca merger talk as shares recover some ground
proactiveinvestors.co.uk · Aug 4, 2026
SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies
prnewswire.com · Aug 4, 2026
More Biotech M&A Is on the Way, Whether an AstraZeneca-Bristol Myers Deal Happens or Not
barrons.com · Aug 4, 2026
AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus
benzinga.com · Aug 3, 2026
Bristol-Myers stock: why AstraZeneca merger is unlikely to happen
invezz.com · Aug 3, 2026
Bristol Myers Squibb Stock Jumps on Reported Merger Talks With AstraZeneca
investopedia.com · Aug 3, 2026
5 Things to Know Before the Stock Market Opens on Monday
investopedia.com · Aug 3, 2026
Analysts baffled by AstraZeneca's interest in Bristol Myers Squibb
proactiveinvestors.com · Aug 3, 2026
AstraZeneca, GameStop, Snap And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com · Aug 3, 2026
Breakfast News: Pharma's $400B Blockbuster Brewing
fool.com · Aug 3, 2026
Analysts baffled by AstraZeneca's interest in Bristol Myers Squibb
proactiveinvestors.co.uk · Aug 3, 2026
AstraZeneca tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
marketwatch.com · Aug 3, 2026
Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZeneca
barrons.com · Aug 3, 2026
Why did AstraZeneca shares fall 6% after Bristol Myers Squibb merger reports?
invezz.com · Aug 3, 2026
AstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb
proactiveinvestors.com · Aug 3, 2026
AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger Talks
wsj.com · Aug 3, 2026
AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
cnbc.com · Aug 3, 2026
AstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb
proactiveinvestors.co.uk · Aug 3, 2026
AstraZeneca shares tumble 7% after reported Bristol Myers talks
reuters.com · Aug 3, 2026
AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report
nypost.com · Aug 2, 2026
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
cnbc.com · Aug 2, 2026
AstraZeneca holds talks with Bristol Myers Squibb on potential megadeal, FT reports
reuters.com · Aug 2, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
prnewswire.com · Jul 30, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
globenewswire.com · Jul 28, 2026
AstraZeneca Cancer Drug Targets Up to $5 Billion in Sales
gurufocus.com · Jul 28, 2026
AstraZeneca's drug pipeine is splitting opinion among City analysts
proactiveinvestors.co.uk · Jul 28, 2026
AstraZeneca PLC (AZN) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jul 27, 2026
AZN Q2 Earnings and Sales Beat, Key Drugs Offset Generic Pressure
zacks.com · Jul 27, 2026
AstraZeneca's $2.63 Earnings Beat Supports $80 Billion Revenue Target
gurufocus.com · Jul 27, 2026
AstraZeneca: Q2 2026 Results Were All Right, But Farxiga Poses Risks
seekingalpha.com · Jul 27, 2026
Astrazeneca (AZN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
zacks.com · Jul 27, 2026
Dow Jumps Over 400 Points; AstraZeneca Shares Rise After Q2 Earnings
benzinga.com · Jul 27, 2026
Astrazeneca Q2 Earnings Call Highlights
marketbeat.com · Jul 27, 2026
AstraZeneca drug prices evolving in response to Trump policy, executive says
reuters.com · Jul 27, 2026
AstraZeneca results: H1 and Q2 2026
businesswire.com · Jul 27, 2026
Why Is AstraZeneca PLC Up or Down Today?
When AstraZeneca PLC (AZN) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a AZN move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why AstraZeneca PLC is up or down today.
How AstraZeneca PLC News Affects the Price
News does not move the AstraZeneca PLC (AZN) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the AstraZeneca PLC Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in AstraZeneca PLC trading volume. That is the chain to watch: headline, sentiment, volume, then the AZN price.
Trade the AstraZeneca PLC News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch AstraZeneca PLC trading volume spike on a big story, check the AstraZeneca PLC price history for context, follow the live AZN price, see the AstraZeneca PLC price prediction, and read the AstraZeneca PLC Fear and Greed Index for mood.
How do you feel about AstraZeneca PLC?
1DFrequently asked questions
Why is AstraZeneca PLC up or down today?
What is the latest AstraZeneca PLC news?
Where does AstraZeneca PLC news come from?
How often is AstraZeneca PLC news updated?
How does AstraZeneca PLC news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.